Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000634963 | SCV000756339 | pathogenic | Infantile neuroaxonal dystrophy | 2022-06-27 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 599 of the PLA2G6 protein (p.Phe599Leu). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PLA2G6 protein function. ClinVar contains an entry for this variant (Variation ID: 529508). This missense change has been observed in individual(s) with clinical features of PLA2G6-related conditions (PMID: 32771225; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). |
Unidad de Genómica Garrahan, |
RCV000634963 | SCV002525868 | uncertain significance | Infantile neuroaxonal dystrophy | 2021-10-19 | criteria provided, single submitter | clinical testing | PM2, PP3. |